AVHHL - AVITA Medical Inc. (RCEL) Q4 2023 Earnings Call Transcript
2024-02-22 23:03:08 ET
AVITA Medical, Inc. (RCEL)
Q4 2023 Earnings Conference Call
February 22, 2024 04:30 PM ET
Company Participants
Jessica Ekeberg - Director, IR
Jim Corbett - CEO
David O'Toole - CFO
Conference Call Participants
Brooks O'Neil - Lake Street Capital Markets
Ross Osborne - Cantor Fitzgerald
Ryan Zimmerman - BTIG
Chris Kallos - MSTF
Madeleine Williams - Wilsons
Lyanne Harrison - Bank of America
Presentation
Operator
Good day and thank you for standing by. Welcome to the AVITA Medical Fourth Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to turn the conference over to your speaker today, Jessica Ekeberg, Director of Investor Relations.
Jessica Ekeberg
Thank you, operator. Welcome to AVITA Medical's fourth quarter and full year 2023 earnings call.
Joining me on today's call are Jim Corbett, Chief Executive Officer; and David O'Toole, Chief Financial Officer.
Today's earnings release is available on our website, www.avitamedical.com under the Investor Relations section.
Before we begin, let me remind you that this call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are neither promises nor guarantees and involve known and unknown risks and uncertainties that could cause actual results to differ materially from any expectations expressed or implied by the forward-looking statements....
AVITA Medical, Inc. (RCEL) Q4 2023 Earnings Call Transcript